SCHEMBL30712748

SCHEMBL30712748

CC1=CC(=O)CC(C)(C)C1COC1OC(CO)C(O)C(O)C1O

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 5/20 0.46
▸ CA12 O43570 4/20 0.44
▸ CA9 Q16790 4/20 0.44
▸ CA1 P00915 3/20 0.44
▸ CA2 P00918 2/20 0.44
▸ BACE1 P56817 4/20 0.42
▸ GAA P10253 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CCNB1 P14635 1/20 0.41
▸ EPHX2 P34913 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38650628 1.00 ACHE (0.46) ACHECA12CA9CA1CA2
SCHEMBL31053942 0.85 ACHE (0.42) ACHECA12CA9CA1CA2
SCHEMBL30712746 0.82 ACHE (0.46) ACHECA9CA1CA2BACE1
SCHEMBL30153685 0.81 TYR (0.45) CA12CA9CA1CA2GAA
SCHEMBL31711467 0.72 NR3C1 (0.32) ALDH1A1KMT2A
SCHEMBL31229542 0.72 TYR (0.44) GAAALDH1A1
SCHEMBL20315376 0.66 GAA (0.65) ACHECA12CA9CA1CA2
SCHEMBL8325931 0.66 GAA (0.65) ACHECA12CA9CA1CA2
SCHEMBL5793535 0.66 GAA (0.65) ACHECA12CA9CA1CA2
SCHEMBL7687892 0.66 GAA (0.59) ACHECA2GAACDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117405791-B Construction method and quality detection method of fingerprint of lung-heat-clearing decoction compound preparation 江西药都樟树制药有限公司 2025-04-18 — — CN disclosed
CN-117405791-A Construction method and quality detection method of fingerprint of lung-heat-clearing decoction compound preparation 江西药都樟树制药有限公司 2024-01-16 — — CN disclosed
Send feedback